HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Natori Selected Research

Ac-PPP-tet

1/2010An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Natori Research Topics

Disease

6Infections
01/2020 - 05/2002
5Glomerulonephritis
01/2016 - 02/2002
3Nephrosis
01/2019 - 02/2004
3Colitis
12/2006 - 05/2002
3Hemolytic-Uremic Syndrome
11/2005 - 05/2002
2Proteinuria
09/2010 - 02/2004
2Diarrhea
12/2006 - 05/2002
1Human Influenza (Influenza)
01/2020
1Kidney Neoplasms (Kidney Cancer)
01/2018
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018
1Neoplasms (Cancer)
01/2018
1Vasculitis (Vasculitides)
01/2016
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2016
1Inflammation (Inflammations)
04/2010
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2010
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2007
1Lissencephaly
10/2007
1Albuminuria
10/2007
1Acute Kidney Injury (Acute Renal Failure)
11/2005
1Fibrosis (Cirrhosis)
06/2004
1IGA Glomerulonephritis (IGA Nephropathy)
06/2002
1Disease Progression
06/2002
1Hemorrhage
02/2002

Drug/Important Bio-Agent (IBA)

4Shiga Toxin (Shigella Toxin)IBA
12/2006 - 05/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 09/2010
3Virulence Factors (Pathogenicity Factors)IBA
01/2010 - 06/2002
2LipidsIBA
01/2020 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2019 - 02/2004
2Messenger RNA (mRNA)IBA
09/2010 - 02/2004
2CytokinesIBA
09/2010 - 04/2010
2Puromycin AminonucleosideIBA
06/2004 - 02/2004
1Pharmaceutical PreparationsIBA
01/2020
1Viral HemagglutininsIBA
01/2020
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2018
1Claudin-1IBA
01/2018
1Peptide Hydrolases (Proteases)FDA Link
01/2018
1Matrix Metalloproteinases (MMPs)IBA
01/2018
1Cadherins (E-Cadherin)IBA
01/2018
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2016
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2016
1Peroxidase (Myeloperoxidase)IBA
01/2016
1AntibodiesIBA
01/2016
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2010
1Interferon-gamma (Interferon, gamma)IBA
09/2010
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2010
1Interleukin-12 (IL 12)IBA
09/2010
1Atorvastatin (Lipitor)FDA Link
09/2010
1Shiga Toxin 2IBA
01/2010
1Ac-PPP-tetIBA
01/2010
1Streptozocin (Streptozotocin)FDA Link
10/2007
1AlbuminsIBA
10/2007
1Dyneins (Dynein)IBA
10/2007
1CreatinineIBA
11/2005
1Urea (Carbamide)FDA LinkGeneric
11/2005
1NitrogenIBA
11/2005
1Hydroxyproline (4 Hydroxyproline)IBA
06/2004
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
02/2004
1GlyceraldehydeIBA
02/2004
1Heparitin Sulfate (Heparan Sulfate)IBA
02/2004
1globotrioseIBA
02/2004
1PolymersIBA
02/2004
1Phosphates (Orthophosphate)IBA
02/2004
1Oxidoreductases (Dehydrogenase)IBA
02/2004
1AgrinIBA
02/2004
1EnzymesIBA
02/2004
1IsoenzymesIBA
02/2004
1ChemokinesIBA
06/2002
1lymphotactinIBA
06/2002
1Chemokine CCL4IBA
06/2002
1Chemokine CX3CL1IBA
06/2002
1CarbohydratesIBA
05/2002
1ThrombomodulinIBA
02/2002
1LipopolysaccharidesIBA
02/2002
1Heparin (Liquaemin)FDA LinkGeneric
02/2002

Therapy/Procedure

1Intraperitoneal Injections
02/2004